2A - the "go-to" technology for transgene co-expression by Minskaia, Ekaterina & Luke, Garry Alec
Open AccessCommentary
Single-Cell Biology
ISSN: 2168-9431
Si
ng
le C
ell Biology Minskaia and Luke, Single Cell Biol 2015, S1
http://dx.doi.org/10.4172/2168-9431.S1-004
Single Cell Biol ISSN: 2168-9431 SCB, an open access journal Journal of Single Cell Genomics & Proteomics
2A - The “go-to” Technology for Transgene Co-expression
Ekaterina Minskaia1* and Garry A. Luke2
1Institute of Molecular Medicine, Av. Prof Egas Moniz, 1649-028, Lisbon, Portugal
2Biomedical Sciences Research Complex, North Haugh, University of St. Andrews, St. Andrews, Fife, Scotland
Abstract
In order to co-express multiple genes for biotechnological and biomedical applications, several approaches 
have been used with varying degrees of success. Currently, internal ribosome entry site (IRES) elements and “self-
cleaving” 2A peptides are the most widely used. The length of the IRES can be prohibitive and IRES-dependent 
translation of the second open reading frame is often significantly reduced. 2A peptides have gained in popularity 
due to their small size and ability to consistently produce discrete proteins at an equal level. Here, we promote the 
use of these sequences as the “go-to” technology for co-expression of multiple proteins.
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Commentary 
Many biotechnological and biomedical applications rely on the 
effective co-expression of multiple proteins. So far, multiple genes have 
been expressed via: (i) monocistronic vectors e.g. viral co-infection 
or co-transfection of plasmids expressing one protein each; fusion 
proteins; fusion proteins incorporating proteinase cleavage sites and (ii) 
polycistronic vectors where multiple genes are assembled either under 
the control of multiple promoters or a single promoter. IRES sequences 
have been used as a method to separate two coding sequences under 
the control of a single promoter. Despite their widespread use, they are 
relatively large (~600 base pairs) and expression of the downstream 
gene is significantly less efficient than the upstream gene [1]. A different 
approach using the 2A oligopeptide sequence allows multiple discrete 
proteins to be synthesized from a single strand of RNA, which also 
functions as a messenger RNA (mRNA). Not only is the 2A sequence 
smaller (54-174bp) than IRES elements, co-expression of proteins 
linked via 2A is independent of the cell type (cleavage activity is only 
dependent on eukaryotic ribosomes) and proteins are produced with 
equimolar stoichiometry [2-4]. The potential of this system is vividly 
demonstrated in the yeast Pichia pastoris by the functional co-expression 
of the carotenoid and violacein biosynthetic pathways encoded by nine 
genes from a polycistronic construct based on 2A peptides: the highest 
number of genes expressed in such a co-ordinated fashion so far [5]. 
IRES and 2A sequences have been used successfully in an impressive 
array of studies: at least 200 in the case of IRES elements and almost 900 
in the case of 2A peptides making 2A the “go-to” option for protein co-
expression [6-9]. Here we provide a short update on the history of 2A 
and cover some applications of 2A co-expression technology.
The Foot-and-mouth disease virus (FMDV) 2A sequence (hereafter 
“F2A”) mediates “self-processing” by a novel translational effect 
variously referred to as ‘ribosome skipping’, ‘stop-go’ and ‘stop-carry on’ 
translation [10-12]. 2A peptide cleavage has been studied in various cell 
types using various recombinant polyproteins and artificial reporter 
polyprotein systems comprising chloramphenicol acetyltransferase 
(CAT), β-glucuronidase (GUS), and fluorescent proteins (FPs e.g. GFP, 
RFP, YFP) [13-16]. It was demonstrated that F2A plus the N-terminal 
proline of the 2B downstream protein co-translationally ‘self-cleaved’ 
at the glycyl-prolyl pair site corresponding to the 2A/2B junction 
(LLNFDLLKLAGDVESNPG↓P-) (Figure 1) [17-25]. Later work shows 
the length of the F2A used is also important for cleavage in vitro and 
in vivo - higher cleavage efficiency was reported when longer versions 
of 2A with N-terminal extensions derived from FMDV capsid protein 
1D upstream of 2A were used [18,20,26-33]. Importantly, the co-
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translational nature of this cleavage means that by including various 
signal sequences within 2A polyproteins, either up- or downstream of 
2A, proteins can be either targeted co-translationally to the exocytic 
pathway or post-translationally to different cellular compartments 
[34-36]. Of the many 2A peptides identified to date [10,27,37], four 
have been widely used in biotechnology and biomedicine: F2A, equine 
rhinitis A virus (“E2A”), porcine teschovirus-1 (“P2A”) and Thosea 
asigna virus (“T2A”) (Table 1) [2-4,36,38-43]. 
Finally, it should be noted that (i) 2A remains as a C-terminal 
extension of the upstream gene, and (ii) proline forms the N terminus 
of the downstream gene. The presence of N-terminal proline does 
not seem to affect proteins which are metabolically stable [44], but 
when the authentic C-terminus is required for activity or subcellular 
targeting of certain proteins, they should either be encoded at the 
C-terminus of the polyprotein or followed by cleavage sequences of the 
mammalian Kex2p homologue, furin (-↓RRRR-, -↓RKRR-, -↓RRKR-), 
which removes the 2A “tag” [21,38]. The presence of 2A, however, can 
be used for detection of protein expression and localization using anti-
2A antibodies [2,3]. 
Figure 1: Schematic presentation of co-translational cleavage via “self-
cleaving” 2A peptide. Gene sequences 1 (stop codon removed) and 2 are 
linked together into a single (trans) gene via a 2A sequence. The translation 
products are synthesized in an equimolar ratio, although, protein 1 upstream 
of 2A bears a C-terminal extension of 2A, and protein 2 bears an N-terminal 
proline residue.
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F2A is the most widely used 2A sequence in plant biotechnology 
and has been used to target multiple proteins to various subcellular 
compartments [13,34,45,46], to improve disease resistance [47,48], 
drought-resistance [49] and nutritional value through metabolome 
engineering [10,50]. Vitamin A deficiency (VAD) is a major global 
health issue which affects hundreds of millions of people. This problem 
arises because rice, the staple food source in countries where VAD is 
prevalent, does not produce vitamin A or its precursor β-carotene, 
which have a number of vital functions in the body including growth. 
Since 2000, researchers have been engineering a transgenic variety of 
rice referred to as “golden rice” (Oryza sativa, GR) that includes the 
biosynthetic pathway for production of β-carotene [51,52]. Engineering 
the pathway into (carotenoid-free) rice endosperm requires two 
carotenoid biosynthetic genes, phytoene synthase (psy) and carotene 
desaturase (crtl) [53]. To avoid the problems of promoter interference 
(GR1 and 2 require two promoters), psy from Capsicum and crtl from 
Pantoea, were linked via 2A (psy-F2A-crtl; pPAC construct) or IRES 
(psy-IRES-crtl; pPIC construct) and placed under the control of the 
rice globulin promoter [50]. GR3 of transgenic PAC had a much more 
intense golden colour than did the PIC transformants, demonstrating 
that the 2A construct performed better than the IRES construct in 
terms of carotenoid production.
F2A and ‘2A-like’ sequences have been used extensively in genetic 
engineering of T cells for adoptive cell therapies [39-41], human 
stem cells [42,54,55] and in the induction of pluripotent stem cells 
[23,25,43]. For example, the genes encoding four transmembrane 
proteins necessary for the assembly of the CD3 complex were co-
expressed from a polycistronic vector containing three 2As [36] and co-
expression of four transcription factors in a [KLF4-E2A-OCT3/4-T2A-
SOX2-P2A-c-Myc]-IRES-hrGFP construct resulted in the generation 
of induced pluripotent stem (iPS) cells from somatic cells [56]. High 
levels of functional monoclonal antibodies were produced by linking 
the antibody heavy and light chain sequences with F2A in the context 
of AAV-mediated gene transfer [21]. 2As were used to co-express 
tumor associated antigens (TCR) α- and β-chains to treat metastatic 
melanoma, colorectal cancer, renal cell carcinomas and many other 
types of malignant diseases [57-59]. Significant anti-tumour responses 
were observed in the clinic using monoclonal antibodies by co-
expressing cytotoxic T-lymphocyte-associated antigen (CTLA-4) heavy 
and light chains [60].
 Finally, we think ‘2A-like’ sequences are able to function both 
as a signal sequence and as a translational recoding element - this 
leads to partitioning of the translation products between two sub-
cellular sites (dual protein targeting). We have identified some 
2A-like sequences at the N-terminus of NLRs in the genome of the 
purple sea urchin Strongylocentrotus purpuratus that were putative 
signal sequences. Constructs encoding wild-type [Sp2A-cherryFP-
T2A-GFP] or a mutated, cleavage inactive form of Sp2A were used 
to transfect mammalian HeLa cells – with both constructs GFP was 
evenly distributed throughout the cell, wild-type Sp2A lead to cherryFP 
localization throughout the cell and mutated Sp2A acting as a signal 
lead to cherryFP localization in the exocytic pathway [37,61].
In conclusion, with the number of studies that have successfully 
used F2A and ‘2A-like’ sequences approaching 1000, these small 
peptides are proving to be the ‘go-to’ technology for co-expression of 
multiple proteins.
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